نتایج جستجو برای: npm1 mutation

تعداد نتایج: 292091  

2010
Maria Braoudaki Chrissa Papathanassiou Katerina Katsibardi Natalia Tourkadoni Kalliopi Karamolegou Fotini Tzortzatou-Stathopoulou

BACKGROUND Mutations in the nucleophosmin (NPM1) gene have been solely associated with childhood acute myeloid leukemia (AML). We evaluated the frequency of NPM1 mutations in childhood AML, their relation to clinical and cytogenetic features and the presence of common FLT3 and RAS mutations. RESULTS NPM1 mutations were found in 8% of cases. They involved the typical type 'A' mutation and one ...

2017
Narges Rezaei Nargess Arandi Behnaz Valibeigi Sezaneh Haghpanah Mehdi Khansalar Mani Ramzi

OBJECTIVE In this study, we evaluated the frequency of FMS-like tyrosine kinase 3 (FLT3-ITD and FLT3-TKD) and nucleophosmin (NPM1) mutations in Iranian patients with cytogenetically normal acute myeloid leukemia (CN-AML). The clinical and laboratory characteristics were compared between wild-type and mutant cases. MATERIALS AND METHODS Seventy newly diagnosed de novo AML patients were recruit...

2018
Dushyant Kumar Anurag Mehta Manoj Kumar Panigrahi Sukanta Nath Kandarpa Kumar Saikia

OBJECTIVE Nucleophosmin-1 (NPM1) mutations have prognostic importance in acute myeloid leukemia (AML) patients with intermediate-risk karyotype at diagnosis. Approximately 30% of newly diagnosed cytogenetically normal AML (CN-AML) patients harbor the NPM1 mutation in India. In this study we compared the efficiency of three molecular techniques in detecting NPM1 mutation in peripheral blood and ...

2016
Su Yeon Jo Sang Hyuk Park In-Suk Kim Jongyoun Yi Hyung-Hoi Kim Chulhun L. Chang Eun Yup Lee Young-Uk Cho Seongsoo Jang Chan-Jeoung Park Hyun-Sook Chi

BACKGROUND Nucleophosmin gene (NPM1) mutation may be a good molecular marker for assessing the clinical status and predicting the outcomes in AML patients. We evaluated the applicability of NPM1 type A mutation (NPM1-mutA) quantitation for this purpose. METHODS Twenty-seven AML patients with normal karyotype but bearing the mutated NPM1 were enrolled in the study, and real-time quantitative P...

Journal: :Haematologica 2008
Chetsada Boonthimat Wanna Thongnoppakhun Chirayu U Auewarakul

NPM1 mutations were investigated in 400 Southeast Asian leukemia patients and were detectable in 105 cases (26.25%) of acute myeloid leukemia but in no cases of acute lymphoid leukemia or chronic myeloid leukemia. Eight novel and 5 known mutations were identified. All predicted novel proteins shared the last five amino acids VSLRK with the similar gain of nuclear exporting signal motif as known...

Journal: :Annals of clinical and laboratory science 2012
Milica Radojkovic Natasa Tosic Natasa Colovic Slobodan Ristic Sonja Pavlovic Milica Colovic

We report a case of de novo acute myeloid leukemia (AML) with unstable FLT3 gene mutations and stable NPM1 mutation. FLT3/D835 and NPM1 (Type A) mutations were detected upon diagnosis. During the relapse, the FLT3/D835 mutation changed to an FLT3/ITD mutation while the NPM1 (Type A) mutation was retained. Cytogenetic analyses showed the normal karyotype at diagnosis and relapse. Our findings ra...

Journal: :Blood 2013
Paolo Sportoletti Emanuela Varasano Roberta Rossi Oxana Bereshchenko Debora Cecchini Ilaria Gionfriddo Niccolò Bolli Enrico Tiacci Tamara Intermesoli Pamela Zanghì Arianna Masciulli Maria Paola Martelli Franca Falzetti Massimo F Martelli Brunangelo Falini

The NPM1 mutation is the most frequent genetic alteration thus far identified in acute myeloid leukemia (AML). Despite progress in the clinical and biological characterization of NPM1-mutated AML, the role of NPM1 mutation in leukemogenesis in vivo has not been fully elucidated. We report a novel mouse model that conditionally expresses the most common human NPM1 mutation (type A) in the hemato...

Journal: :Blood 2011
Brunangelo Falini Maria Paola Martelli Niccolò Bolli Paolo Sportoletti Arcangelo Liso Enrico Tiacci Torsten Haferlach

After the discovery of NPM1-mutated acute myeloid leukemia (AML) in 2005 and its subsequent inclusion as a provisional entity in the 2008 World Health Organization classification of myeloid neoplasms, several controversial issues remained to be clarified. It was unclear whether the NPM1 mutation was a primary genetic lesion and whether additional chromosomal aberrations and multilineage dysplas...

Journal: :Blood 2011
Wen-Chien Chou Sheng-Chieh Chou Chieh-Yu Liu Chien-Yuan Chen Hsin-An Hou Yuan-Yeh Kuo Ming-Cheng Lee Bor-Sheng Ko Jih-Luh Tang Ming Yao Woei Tsay Shang-Ju Wu Shang-Yi Huang Szu-Chun Hsu Yao-Chang Chen Yi-Chang Chang Yi-Yi Kuo Kuan-Ting Kuo Fen-Yu Lee Ming-Chi Liu Chia-Wen Liu Mei-Hsuan Tseng Chi-Fei Huang Hwei-Fang Tien

The studies concerning clinical implications of TET2 mutation in patients with primary acute myeloid leukemia (AML) are scarce. We analyzed TET2 mutation in 486 adult patients with primary AML. TET2 mutation occurred in 13.2% of our patients and was closely associated with older age, higher white blood cell and blast counts, lower platelet numbers, normal karyotype, intermediate-risk cytogeneti...

Journal: :Blood 2009
Friederike Schneider Eva Hoster Michael Unterhalt Stephanie Schneider Annika Dufour Tobias Benthaus Gudrun Mellert Evelin Zellmeier Stefan K Bohlander Michaela Feuring-Buske Christian Buske Jan Braess Susanne Fritsch Achim Heinecke Maria C Sauerland Wolfgang E Berdel Thomas Buechner Bernhard J Woermann Wolfgang Hiddemann Karsten Spiekermann

Mutations in the NPM1 gene represent the most frequent genetic alterations in patients with acute myeloid leukemia (AML) and are associated with a favorable outcome. In 690 normal karyotype (NK) AML patients the complete remission rates (CRs) and the percentage of patients with adequate in vivo blast cell reduction 1 week after the end of the first induction cycle were significantly higher in N...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید